Does albumin reduce mortality in critically ill people? Evidence update - Summary of a Cochrane Review

Effective Health Care Research Consortium (2003) Does albumin reduce mortality in critically ill people? Evidence update - Summary of a Cochrane Review. Liverpool, Effective Health Care Research Consortium, Liverpool School of Tropical Medicine.

Preview

Text TR_Human-albumin_AUG03.pdf - Published Version Available under License Creative Commons Attribution No Derivatives. Download (247kB)

Abstract

There is no evidence that albumin administration reduces the risk of death in critically ill patients with hypovolaemia, burns or hypoalbuminaemia.

Item Type:	Other
Corporate Authors:	Effective Health Care Research Consortium
Additional Information:	Produced by the Effective Health Care Alliance Programme, Liverpool School of Tropical Medicine, supported by the Department of International Development UK, (http://www.liv.ac.uk/evidence). Adapted from The Albumin Reviewers (Alderson P, Bunn F, Lefebvre C, Li Wan Po A, Li L, Roberts I, Schierhout G). Human albumin solution for resuscitation and volume expansion in critically ill patients (Cochrane Review). In: The Cochrane Library, Issue 3, 2003.
Uncontrolled Keywords:	Cochrane Review CD001208, Critical Illness, Plasma Substitutes, Serum Albumin, Serum Globulins, Trauma, Evidence Update
Subjects:	WH Hemic and Lymphatic Systems > Hematologic Diseases. Immunologic Factors. Blood Banks > WH 400 Fluid elements. Plasma. Serum. Blood proteins. Blood protein disorders
Faculty: Department:	Groups (2002 - 2012) > International Health Group
Related URLs:	http://onlinelibrary.wiley.com/o/cochran... http://www.liv.ac.uk/evidence
Depositing User:	Martin Chapman
Date Deposited:	10 Sep 2010 10:40
Last Modified:	06 Feb 2018 13:01
URI:	https://archive.lstmed.ac.uk/id/eprint/1418

Statistics

View details

Actions (login required)

Edit Item